Roche’s Tecentriq secures FDA approval for small cell lung cancer treatment

Roche’s subsidiary, Genentech, has announced a significant breakthrough with the US Food and Drug Administration (FDA) approval of Tecentriq (atezolizumab). This new approval marks a ... Read More